Literature DB >> 6805009

Behavioral effects of chronic phencyclidine administration in rats.

R D Sturgeon, R G Fessler, S F London, H Y Meltzer.   

Abstract

The development of tolerance to phencyclidine (PCP) was examined in rats using behavioral rating scales with simultaneous measurements of locomotor activity, stereotyped behaviors, and ataxia. Significant tolerance to the stereotyped behaviors and ataxia induced by 5 or 10 mg/kg PCP was found on day 5 of chronic drug treatment. Because ataxia interferes with PCP-induced locomotor activity (Sturgeon et al. 1979), tolerance to PCP-induced ataxia produced an increase in locomotor activity on day 5. Tolerance to the ataxia, but not to the stereotyped behaviors induced by PCP, was more prominent after day 15 of PCP administration than after day 5. Administration of PCP for 15 days resulted in significant decrease in locomotor activity for the 5 mg/kg group but not for the 10 mg/kg group. These results suggest that behavioral tolerance, rather than supersensitivity, develops after chronic PCP administration. The effects of PCP returned to baseline over a 14-day withdrawal period for rats treated with 5 mg/kg PCP for 15 days. Rats treated with 10 mg/kg PCP for 15 days still had not returned to baseline when tested 28 days after cessation of PCP treatment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6805009     DOI: 10.1007/BF00430755

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

1.  Anticholinesterase and antiacetylcholine activity of 1-phenylcyclohexylamine derivatives.

Authors:  Y Kloog; M Rehavi; S Maayani; M Sokolovsky
Journal:  Eur J Pharmacol       Date:  1977-10-01       Impact factor: 4.432

2.  On the interaction of drugs with the cholinergic nervous system. II. Cross-tolerance between phencyclidine derivatives and cholinergic drugs.

Authors:  I Pinchasi; S Maayani; Y Egozi; M Sokolovsky
Journal:  Psychopharmacology (Berl)       Date:  1978-01-31       Impact factor: 4.530

3.  Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy.

Authors:  D S Segal; A J Mandell
Journal:  Pharmacol Biochem Behav       Date:  1974 Mar-Apr       Impact factor: 3.533

4.  Some effects of an hallucinogenic drug (phencyclidine) on neurohumoral substances.

Authors:  B E Leonard; S R Tonge
Journal:  Life Sci I       Date:  1970-10-15

5.  Effects of acute and chronic phencyclidine on neurotransmitter enzymes in rat brain.

Authors:  L L Hsu; R C Smith; C Rolsten; D E Leelavathi
Journal:  Biochem Pharmacol       Date:  1980-09-15       Impact factor: 5.858

6.  Apparent tolerance to some aspects of amphetamine stereotypy with long-term treatment.

Authors:  G V Rebec; D S Segal
Journal:  Pharmacol Biochem Behav       Date:  1980-12       Impact factor: 3.533

7.  The effects of phencyclidine on operant behavior in the rat: biphasic effect and tolerance development.

Authors:  T F Murray
Journal:  Life Sci       Date:  1978-01       Impact factor: 5.037

8.  Phencyclidine-induced stereotyped behavior in monkeys: antagonism by pimozide.

Authors:  R F Schlemmer; J A Jackson; K L Preston; J P Bederka; D L Garver; J M Davis
Journal:  Eur J Pharmacol       Date:  1978-12-01       Impact factor: 4.432

9.  Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats.

Authors:  R D Sturgeon; R G Fessler; H Y Meltzer
Journal:  Eur J Pharmacol       Date:  1979-11-16       Impact factor: 4.432

10.  The effects of acute and chronic phencyclidine on schedule-controlled behavior in the squirrel monkey.

Authors:  L D Chait; R L Balster
Journal:  J Pharmacol Exp Ther       Date:  1978-01       Impact factor: 4.030

View more
  9 in total

1.  Functional reactivity of the dopaminergic system following acute and chronic ketamine treatments.

Authors:  A R Owolabi; M A Akanmu; O E Ukponmwan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-12       Impact factor: 3.000

2.  Comparison of the pharmacologic effects of N-allylnormetazocine and phencyclidine: sensitization, cross-sensitization, and opioid antagonist activity.

Authors:  E T Iwamoto
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Evidence for multiple opiate receptor involvement in different phencyclidine-induced unconditioned behaviors in rats.

Authors:  B D Greenberg; D S Segal
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology.

Authors:  Evan J Kyzar; Christopher Collins; Siddharth Gaikwad; Jeremy Green; Andrew Roth; Louie Monnig; Mohamed El-Ounsi; Ari Davis; Andrew Freeman; Nicholas Capezio; Adam Michael Stewart; Allan V Kalueff
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-01-09       Impact factor: 5.067

5.  Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats.

Authors:  Maria Sabrina Spano; Liana Fattore; Francesca Cadeddu; Walter Fratta; Paola Fadda
Journal:  Psychopharmacology (Berl)       Date:  2012-08-19       Impact factor: 4.530

6.  Effects of phencyclidine, haloperidol, and naloxone on fixed-interval performance in rats.

Authors:  G C Wagner; D B Masters; A Tomie
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  An assessment of the spontaneous activity of rats administered morphine, phencyclidine, or nicotine using automated and observational methods.

Authors:  E T Iwamoto
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Role of nitric oxide in the development of tolerance and sensitization to behavioural effects of phencyclidine in mice.

Authors:  Y Noda; K Yamada; Y Komori; H Sugihara; H Furukawa; T Nabeshima
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

9.  Phencyclidine dose optimisation for induction of spatial learning and memory deficits related to schizophrenia in C57BL/6 mice.

Authors:  Mohd Aizat Zain; Elham Rouhollahi; Vijayapandi Pandy; Vasudevan Mani; Abu Bakar Abdul Majeed; Won Fen Wong; Zahurin Mohamed
Journal:  Exp Anim       Date:  2018-05-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.